COMBINATION THERAPY WITH ADENOSINE RECEPTOR ANTAGONISTS

Disclosed herein are compounds, compositions, formulations, and methods for modulating the A2B adenosine receptor in combination with immune checkpoint inhibitors in mammals with cancer. En el presente documento se describen compuestos, composiciones, formulaciones y métodos para modular el receptor...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	YAO Lina, ELZEIN Elfatih, LIU Jiwen, FAN Peidong
Format:	Patent
Sprache:	eng ; spa
Schlagworte:	ADHESIVES CHEMISTRY DYES HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE LAKES MEDICAL OR VETERINARY SCIENCE METALLURGY MISCELLANEOUS APPLICATIONS OF MATERIALS MISCELLANEOUS COMPOSITIONS MORDANTS NATURAL RESINS ORGANIC CHEMISTRY ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES PAINTS POLISHES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Disclosed herein are compounds, compositions, formulations, and methods for modulating the A2B adenosine receptor in combination with immune checkpoint inhibitors in mammals with cancer. En el presente documento se describen compuestos, composiciones, formulaciones y métodos para modular el receptor de adenosina A2B en combinación con inhibidores de puntos de control inmunitarios en mamíferos con cáncer.